The world of finance, connected.EN / Global
Sa
CompanyCompany profileReviewed 2026-10-23

Sanofi

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.

Sources and references ↗
COMPANY PROFILE / 19 SOURCE-LINKED FIELDS

Basic company information

Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.

Ticker / security symbols
SNY, SNYNF [1]
Listing exchanges
Nasdaq, OTC [1]
SEC industry
Pharmaceutical Preparations [1]
Business sectors
pharmaceutical industry [2]
Company / filing name
Sanofi [1]
Headquarters location
Paris [2]
Business address
46 AVENUE DE LA GRANDE ARMEE, PARIS, I0, 75017 [1]
Founded
2004-08-20 [2]
Legal form
public limited company with a board of directors (n.o.s.) [2]
Incorporation jurisdiction
France [1]
Leadership in background record
Paul Hudson [2]
Official website
https://www.sanofi.us/; https://www.sanofi.com/ [2]
Employees
106,566 · reported year 2017 [2]
Annual revenue
EUR 41,081,000,000 · reported year 2024 [2]
Fiscal year end
December 31 (SEC record) [1]
ISIN (reported securities)
FR0000120578 [2]
CIK
0001121404 [1]
SIC code
2834 [1]
Country in background record
France [2]

Company positioning and business

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000. [3]

Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. [3]

Background text: Wikipedia contributors, Sanofi. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.

Management and corporate governance

The Wikidata background record identifies Paul Hudson in the chief-executive role. This background entry is not an official confirmation of the current board or executive roster. [2]

Understanding company scale

Employees: 106,566 · reported year 2017. [2]

Annual revenue: EUR 41,081,000,000 · reported year 2024. [2]

Financial year, securities and disclosures

The SEC submissions record gives Sanofi a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]

Listed securities: SNY (Nasdaq), SNYNF (OTC). Multiple symbols may represent different share classes or securities of the same registrant. [4]

History and key events

  1. Founding / inception date recorded in Wikidata. [2]

  2. Form 20-F filed; reporting period ends 2025-12-31. [5]

Financial results and regulatory disclosures

Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.

Source-verified relationships

Sanofi → Listed on → Nasdaq [1]
Sanofi → Listed on → OTC [1]
Sanofi → SEC industry classification → Pharmaceutical Preparations [1]

Companies in the same industry

Comparison candidates share the SEC SIC classification 2834. This does not imply ownership, partnership or trading relationships.

Related entities and concepts

Frequently asked questions

When was Sanofi founded?

Founded: 2004-08-20. The linked source provides the background record. [2]

Where is the headquarters of Sanofi?

Headquarters location: Paris. The linked source provides the background record. [2]

Which business sectors are recorded for Sanofi?

Business sectors: pharmaceutical industry. The linked source provides the background record. [2]

RELATION MAP

Sanofi relationship map

Drag to rotate · Scroll to zoom
Sanofi

Select a node to inspect its relationship and source.

3 verified direct relationships. Industry peers are not relationship edges.

Sources and review dates

  1. SEC — Sanofi filing identity and securities ↗
  2. Wikidata — company background record (CC0) ↗
  3. Wikipedia contributors — Sanofi (CC BY-SA 4.0) ↗
  4. SEC securities directory ↗
  5. Company chronology / filing ↗

Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.

Content preparation: source-based compilation with AI assistance. See methods and attribution. Named sources identify the underlying records; no individual expert review is claimed.